search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Infection Control & Hospital Epidemiology (2019), 40,40–46 doi:10.1017/ice.2018.263


Original Article


Bronchoscope-associated clusters of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae


Alison L. Galdys MD1,2,3,a, Jane W. Marsh PhD1,2,a, Edgar Delgado RRT, FAARC4, A. William Pasculle ScD2,5, Marissa Pacey BS2, Ashley M. Ayres BS, CIC3, Amy Metzger BS, MT (ASCP), CIC, CHI3, Lee H. Harrison MD1,2,3 and


Carlene A. Muto MD, MS1,2,3 1University of Pittsburgh Division of Infectious Diseases, Pittsburgh, Pennsylvania, 2University of Pittsburgh Microbial Genomic Epidemiology Laboratory (MiGEL), Pittsburgh, Pennsylvania, 3University of Pittsburgh Medical Center Presbyterian Infection Prevention and Control, Pittsburgh, Pennsylvania, 4University of Pittsburgh Medical Center Respiratory Care Department, Pittsburgh, Pennsylvania and 5University of Pittsburgh Department of Pathology, Pittsburgh, Pennsylvania


Abstract


Objective: Recovery of multidrug-resistant (MDR) Pseudomonas aeruginosa and Klebsiella pneumoniae from a cluster of patients in the medical intensive care unit (MICU) prompted an epidemiologic investigation for a common exposure. Methods: Clinical and microbiologic data from MICU patients were retrospectively reviewed, MICU bronchoscopes underwent culturing and borescopy, and bronchoscope reprocessing procedures were reviewed. Bronchoscope and clinical MDR isolates epidemiologically linked to the cluster underwent molecular typing using pulsed-field gel electrophoresis (PFGE) followed by whole-genome sequencing. Results: Of the 33 case patients, 23 (70%) were exposed to a common bronchoscope (B1). Both MDR P. aeruginosa and K. pneumonia were recovered from the bronchoscope’s lumen, and borescopy revealed a luminal defect. Molecular testing demonstrated genetic relatedness among case patient and B1 isolates, providing strong evidence for horizontal bacterial transmission. MDR organism (MDRO) recovery in 19 patients was ultimately linked to B1 exposure, and 10 of 19 patients were classified as belonging to an MDRO pseudo-outbreak. Conclusions: Surveillance of bronchoscope-derived clinical culture data was important for early detection of this outbreak, and whole- genome sequencing was important for the confirmation of findings. Visualization of bronchoscope lumens to confirm integrity should be a critical component of device reprocessing.


(Received 11 June 2018; accepted 24 September 2018; electronically published 19 November 2018)


Millions of endoscopic procedures are performed in US hospitals every year.1 Over the last decade, reports have implicated endo- scopes as a source of infectious disease outbreaks and pseudo- outbreaks.2–6 Recently, an increasing number of US hospitals have reported multidrug-resistant (MDR) organism clusters linked to endoscopes.7–9 In November of 2014, a cluster of patients with bronchosco-


pically obtained clinical cultures positive for carbapenem-resistant Klebsiella pneumoniae (CR-KP) and gentamicin-resistant MDR Pseudomonas aeruginosa (MDR-PA) was identified in the medical intensive care unit (MICU) at University of Pittsburgh Medical Center-Presbyterian Hospital (UPMC-P), a 757-bed urban


Author for correspondence: Alison L. Galdys, 420 Delaware Street SE, MMC 250,


Minneapolis, MN 55455. E-mail: galdys@umn.edu PREVIOUS PRESENTATION: These data were presented in part (abstract 7176) at the Society for Healthcare Epidemiology of America Annual Meeting onMay 14, 2015, in


Orlando, Florida. a Authors of equal contribution.


Cite this article: Galdys AL, et al. (2019). Bronchoscope-associated clusters of


multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae. Infection Control & Hospital Epidemiology 2019, 40, 40–46. doi: 10.1017/ ice.2018.263


© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved.


teaching hospital in Pittsburgh, Pennsylvania. Each of the patients in this cluster had no prior history of isolation of CR-KP or MDR-PA from clinical cultures. An epidemiologic investigation was conducted under the auspices of the infection prevention department’s role in patient safety to identify a common infection source.


Methods Epidemiologic investigation


In November 2014, CR-KP and MDR-PA isolates were identified in a bronchoalveolar lavage (BAL) specimen from a MICU patient without recent health care. This finding was unexpected. Over the next 3 weeks, clinical cultures taken either during or after a bronchoscopy procedure from an additional 9 MICU patients grew CR-KP and/or MDR-PA, triggering an epidemio- logic investigation. House-wide CR-KP incident isolates were identified, and potential commonalities were investigated. Ana- lysis by patient care area identified the 32-bed MICU as accounting for 17 of 21 (81%) of the newly identified CR KP


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136